H.K. Vaccine Rollout Hampered by Reliance on Chinese Shots

Hong Kong has expanded vaccine eligibility to healthy adults over 30 due to low uptake among priority groups. Despite securing ample vaccines, public hesitancy remains high, partly due to adverse reactions reported with Sinovac. The initial rollout faced challenges, including delayed approval and lack of data transparency. While Sinovac was prioritized, concerns arose over its safety, especially for the elderly. The situation now allows younger adults to easily access vaccines, but achieving herd immunity may take longer.

Discuss the role of public awareness and education in the vaccination campaign.

What challenges did Hong Kong face in achieving herd immunity?